| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | Dupixent, fka REGN668 | |
| 3 | Generic Name | dupilumab | |
| 4 | Mechanism | IR-4R antibody | |
| 5 | Indication | allergic and immune conditions | |
| 6 | Competition | ||
| 7 | Economics | ||
| 8 | Administration | ||
| 9 | Clinical Trials | ||
| 10 | |||
| 11 | Phase 2 in eosinophilic asthma | ||
| 12 | |||
| 13 | |||
| 14 | |||
| 15 | Phase 1 in asthma |